By Kevin McCauley
Brunswick Group is working both ends of Walgreens’ $6.7B partnership with U.K.-based Alliance Boots that they say will create the “first global pharmacy-led health and wellness enterprise.”
For its investment, the U.S. drugstore chain gets a 45 percent stake in $36B Alliance Boots, which runs more than 3,300 stores in 11 countries.
The combination results in a wholesale pharmaceutical network with 370 centers serving more than 170K pharmacies in 21 countries.
Gregory Wasson, CEO of Walgreens, said the deal leverages the combined strengths of both companies and provides “an ever broader range of innovative, cost-effective products and services to patients and customers across the healthcare landscape.
There are no current plans for jobs cuts. There will be a new name to reflect the heritage of Walgreens and Boots.
Brunswick senior partner Steve Lippin and director Gemma Hart in New York are working media for Walgreens. London partner Justine Mcllroy and director Tim Danaher have those duties for Alliance Boots.
|